Home Comera Life Sciences

Comera Life Sciences

acquired
IPO Delisting
Innovative Biopharmaceutical Developer
Basic
Enterprise Profile

Basic Information

Comera Life Sciences is developing a new generation of bioinnovative biologics to improve patient accessibility, safety, and convenience.Comera Life Sciences is leading a compassionate new era in medicine, applying deep insights into formulation science and technology to transform essential biologics from intravenous (IV) to subcutaneous (SQ) forms. This approach aims to provide patients with the freedom of self-administration, reduce institutional dependency, and place patients at the center of their treatment plans.
Comera Life Sciences, Inc.
Massachusetts,United States of America
less than 15 people
January 01, 2014
info@reformbiologics.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Product Manufacturing
Technology
Biotechnology
Concept
Therapeutic Products Department of Pharmacy
Application Scenarios
Innovative Drugs Biological Products